CRIS Current Research Information System

NICOLETTI, GIORDANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.851
AS - Asia 1.901
EU - Europa 1.638
AF - Africa 142
SA - Sud America 98
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.636
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.805
VN - Vietnam 622
SG - Singapore 488
CN - Cina 441
GB - Regno Unito 440
DE - Germania 220
IT - Italia 206
SE - Svezia 163
HK - Hong Kong 140
FR - Francia 112
UA - Ucraina 98
RU - Federazione Russa 93
IN - India 73
CH - Svizzera 71
BR - Brasile 66
IE - Irlanda 55
CI - Costa d'Avorio 46
JP - Giappone 38
ZA - Sudafrica 37
EE - Estonia 35
TG - Togo 34
NL - Olanda 32
CA - Canada 31
FI - Finlandia 27
BE - Belgio 20
BG - Bulgaria 20
AR - Argentina 14
PH - Filippine 12
PL - Polonia 11
JO - Giordania 10
KR - Corea 10
MX - Messico 10
SC - Seychelles 10
TH - Thailandia 10
RO - Romania 9
ID - Indonesia 8
IQ - Iraq 7
LT - Lituania 7
PK - Pakistan 7
BD - Bangladesh 6
TR - Turchia 6
CL - Cile 5
EC - Ecuador 5
NG - Nigeria 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
EG - Egitto 4
HR - Croazia 4
IR - Iran 4
AU - Australia 3
CZ - Repubblica Ceca 3
ES - Italia 3
GR - Grecia 3
AT - Austria 2
DO - Repubblica Dominicana 2
KE - Kenya 2
KH - Cambogia 2
MY - Malesia 2
PE - Perù 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
BW - Botswana 1
ET - Etiopia 1
JM - Giamaica 1
KG - Kirghizistan 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
YE - Yemen 1
Totale 6.636
Salva come PNG Salva come JPEG
Città #
Southend 367
Singapore 338
Ashburn 326
Fairfield 321
Chandler 286
Wilmington 153
Ann Arbor 143
Hong Kong 137
Houston 135
Woodbridge 134
Seattle 130
Ho Chi Minh City 122
San Jose 114
Hanoi 101
Cambridge 99
Dong Ket 81
Santa Clara 81
Princeton 77
Jacksonville 65
Beijing 63
Bern 61
Dublin 55
Boardman 54
Abidjan 46
Nanjing 40
Westminster 36
Lauterbourg 35
Lomé 34
Padova 34
Los Angeles 33
Bologna 32
Tokyo 32
Bremen 27
Berlin 26
Helsinki 25
Guangzhou 23
Jinan 23
Saint Petersburg 23
Council Bluffs 22
Haiphong 22
San Diego 22
Brussels 20
Dallas 20
Sofia 20
Shenyang 19
Hebei 18
Hefei 17
New York 17
Falkenstein 16
Buffalo 15
Da Nang 15
London 14
Nanchang 14
Redwood City 14
Milan 13
Ottawa 13
Phoenix 13
Atlanta 11
Changsha 11
Des Moines 11
Frankfurt am Main 11
Redondo Beach 11
Tianjin 11
Turin 11
Zhengzhou 11
Amman 10
Mülheim 10
São Paulo 10
Mahé 8
Toronto 8
Dearborn 7
Verona 7
Warsaw 7
Amsterdam 6
Biên Hòa 6
Casalecchio di Reno 6
Chicago 6
Jiaxing 6
Quận Ba 6
Taiyuan 6
Taizhou 6
Fuzhou 5
Haikou 5
Hải Dương 5
Johannesburg 5
Montreal 5
Paris 5
Sassuolo 5
Seoul 5
Washington 5
Yubileyny 5
Abeokuta 4
Barnet 4
Boston 4
Bulle 4
Bình Phước 4
Bühl 4
Can Tho 4
Hangzhou 4
Islamabad 4
Totale 4.525
Salva come PNG Salva come JPEG
Nome #
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome 267
Development of a K-edge micro CT for the study of tumor angiogenesis in small animals 252
Virus-like particle display of HER2 induces potent anti-cancer responses 232
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy 230
Multiorgan Metastasis of Human HER-2+ Breast Cancer in Rag2−/−;Il2rg−/− Mice and Treatment with PI3K Inhibitor 228
Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells. 219
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy 215
Endothelin-3 production by human rhabdomyosarcoma: A possible new marker with a paracrine role. 203
Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model. 203
In silico modeling and in vivo efficacy of cancer preventive vaccinations 199
A Mutation Threshold Distinguishes the Antitumorigenic Effects of the Mitochondrial Gene MTND1, an Oncojanus Function 193
Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice. 188
High metastatic efficiency of human sarcoma cells in Rag2/gamma c double knockout mice provides a powerful test system for antimetastatic targeted therapy 187
Antimetastatic activity of a preventive cancer vaccine. 186
Human responses against HER-2-positive cancer cells in human immune system-engrafted mice. 185
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer 180
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response 180
Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4. 178
Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells 177
Modeling the competition between lung metastases and the immune system using agents. 177
CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity 177
OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis 176
Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas 174
Immunoprevention and immunotherapy of mammary carcinoma 172
Translational immunomics of cancer prevention. 168
NVE-BEZ235 as a new therapeutic option for sarcomas. 163
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis. 162
Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells. 161
Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis. 161
Preclinical in vivo study of new insulin-like growth factor-I receptor-specific inhibitor in Ewing’s sarcoma. 150
Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling. 147
Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER-2/neu oncogene-driven animal model system 146
Molecular and cellular biology of rhabdomyosarcoma 145
null 145
Targeting CD99 in association with doxorubicin: An effective combined treatment for Ewing’s sarcoma 142
Insulin-like growth factor binding protein 3 as an anti-cancer molecule in Ewing's sarcoma. 141
Characterization of Biological Tissues using X-ray Attenuation Data 126
Totale 6.735
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.980
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.980
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021175 0 0 0 0 0 0 0 0 0 0 0 175
2021/2022796 99 20 66 32 61 39 20 45 30 55 198 131
2022/2023991 113 133 65 150 45 65 25 57 125 39 77 97
2023/2024199 6 39 12 23 18 39 16 11 6 15 4 10
2024/2025762 60 82 61 37 160 47 38 25 5 49 29 169
2025/20261.735 133 109 139 131 226 106 150 47 433 172 57 32
Totale 6.735